The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
Open accessAbstract
Targeting cancer cells, as well as the nonmalignant stromal cells cross-presenting the tumor antigen (Ag), can lead to the complete destruction of well-established solid tumors by adoptively transferred Ag-specific cytotoxic T lymphocytes (CTLs). If, however, cancer cells express only low levels of the Ag, then stromal cells are not destroyed, and the tumor escapes as Ag loss variants. We show that treating well-established tumors expressing low levels of Ag with local irradiation or a chemotherapeutic drug causes sufficient release of Ag to sensitize stromal cells for destruction by CTLs. This was shown directly using high affinity T cell receptor tetramers for visualizing the transient appearance of tumor-specific peptide–MHC complexes on stromal cells. Maximum loading of tumor stroma with cancer Ag occurred 2 d after treatment and coincided with the optimal time for T cell transfer. Under these conditions, tumor rejection was complete. These findings may set the stage for developing rational clinical protocols for combining irradiation or chemotherapy with CTL therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Tumor stroma contains activated fi broblasts (23, 24), recently formed immature and leaky capillaries, and many types of infl ammatory cells comparable to a nonhealing wound (25).”
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Immunotherapy and chemotherapy — a practical partnership
Lake, R. A., & Robinson, B. W. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1613 · Cited by 646
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction
Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans, J., Hemmi, S., Hengartner, H., & Zinkernagel, R. M. (2001) · Nature · doi:10.1038/35082583 · Cited by 493
Nowak, A. K., Lake, R. A., Marzo, A. L., Scott, B., Heath, W. R., Collins, E. J., Frelinger, J. A., & Robinson, B. W. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4905 · Cited by 463
Cross-presentation by intercellular peptide transfer through gap junctions
Neijssen, J., Herberts, C., Drijfhout, J. W., Reits, E., Janssen, L., & Neefjes, J. (2005) · Nature · doi:10.1038/nature03290 · Cited by 445
Scott, A. M., Wiseman, G., Welt, S., Adjei, A. A., Lee, F.-T., Hopkins, W., Divgi, C. R., Hanson, L. J., Mitchell, P., Gansen, D. N., et al. (2003) · PubMed · Cited by 438
Combining radiotherapy and immunotherapy: A revived partnership
Demaria, S., Bhardwaj, N., McBride, W. H., & Formenti, S. C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.032 · Cited by 375
Quantitative Analysis of the Contribution of TCR/pepMHC Affinity and CD8 to T Cell Activation
Holler, P. D., & Kranz, D. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00019-0 · Cited by 347
Self-citationWorkshop R: Tumor Immunology, Abstract R1 bis R30
(2001) · Immunobiology · doi:10.1016/s0171-2985(04)70018-2 · Cited by 312
Bystander elimination of antigen loss variants in established tumors
Spiotto, M. T., Rowley, D. A., & Schreiber, H. (2004) · Nature Medicine · doi:10.1038/nm999 · Cited by 260
Self-citationSpiotto, M. T., Yu, P., Rowley, D. A., Nishimura, M. I., Meredith, S. C., Gajewski, T. F., Fu, Y.-X., & Schreiber, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00480-6 · Cited by 236
Self-citationTCRs with high affinity for foreign pMHC show self-reactivity
Holler, P. D., Chlewicki, L. K., & Kranz, D. M. (2003) · Nature Immunology · doi:10.1038/ni863 · Cited by 217
Self-citationWick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., & Schreiber, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.229 · Cited by 195
Self-citationA Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
Wesley, U. V., Albino, A. P., Tiwari, S., & Houghton, A. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.311 · Cited by 190
The role of tumor stroma in the interaction between tumor and immune system
Blankenstein, T. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.008 · Cited by 176
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.
Singh, S., Ross, S. R., Acena, M., Rowley, D. A., & Schreiber, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.139 · Cited by 170
Self-citationTumor Rejection by Disturbing Tumor Stroma Cell Interactions
Ibe, S., Qin, Z., Schüler, T., Preiß, S., & Blankenstein, T. J. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1549 · Cited by 149
Spiotto, M. T., & Schreiber, H. W. (2005) · PubMed · Cited by 68
Self-citationSchreiber, K., Rowley, D. A., Riethmüller, G., & Schreiber, H. W. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.001 · Cited by 55
Self-citationPerdrizet, G. A., Ross, S. R., Stauss, H. J., Singh, S. P., Koeppen, H., & Schreiber, H. W. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.4.1205 · Cited by 30
Self-citationIonizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope
Ciernik, I. F., Romero, P. J., Berzofsky, J. A., & Carbone, D. P. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00226-6 · Cited by 28
Koeppen, H., Acena, M., Drolet, A., Rowley, D. A., & Schreiber, H. W. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231108 · Cited by 16
Self-citation
Cited by
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
DNA methylation and epigenetic inheritance
Holliday, R. (1990) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1990.0015 · Cited by 2,279
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
Self-citationFuertes, M. B., Kacha, A. K., Kline, J., Woo, S.-R., Kranz, D. M., Murphy, K. M., & Gajewski, T. F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101159 · Cited by 1,192
Self-citation
Metadata
- Authors
- Zhang, B., Bowerman, N. A., Salama, J. K., Schmidt, H., Spiotto, M. T., Schietinger, A., Yu, P., Fu, Y.-X., Weichselbaum, R. R., Rowley, D. A., Kranz, D. M., & Schreiber, H.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-01-08
- Volume
- 204
- Issue
- 1
- Pages
- 49-55
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2085991037
- Cited by
- 359
- References
- 27
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.